Literature DB >> 18673191

HCV and autoimmunity.

S Ferri1, L Muratori, M Lenzi, A Granito, F B Bianchi, D Vergani.   

Abstract

Hepatitis C virus (HCV) infection is characterized by a number of autoreactive manifestations, such as autoantibody production, cryoglobulinemia and thyroid disorders. We will analyse critically the mechanisms invoked, and partially documented, to explain such manifestations arising in genetically predisposed individuals exposed to HCV. In particular we will examine the available evidence implicating the virus in lowering the B cell activation threshold, in directly infecting lymphocytes and in inducing self-reactivity through a mechanism of molecular mimicry. We will then move to the HCV related clinical immunopathological manifestations, with a specific attention to the effects of antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18673191     DOI: 10.2174/138161208784746824

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  31 in total

Review 1.  Anti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapy.

Authors:  Gerson Dierley Keppeke; S John Calise; Edward K L Chan; Luis Eduardo C Andrade
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

2.  Molecular mimicry and immune thrombocytopenia.

Authors:  Richard H Aster
Journal:  Blood       Date:  2009-04-23       Impact factor: 22.113

3.  Fulminant myelitis with NMO IgG antibody following treatment with interferon alpha.

Authors:  Nida Usmani; Micheline McCarthy; Kottil W Rammohan; Melissa R Ortega
Journal:  J Neurol       Date:  2013-12-12       Impact factor: 4.849

Review 4.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 5.  Pathogens and autoimmune hepatitis.

Authors:  U Christen; E Hintermann
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

6.  Lupus-like glomerulonephritis: an autoimmune complication of hepatitis C infection.

Authors:  Liliane Hobeika; Monica Srivastava; Mai Vo; Marie D Philipneri; David S Brink; Nadia Wasi; Krista L Lentine
Journal:  CEN Case Rep       Date:  2012-03-27

7.  Chronic hepatitis C virus infection breaks tolerance and drives polyclonal expansion of autoreactive B cells.

Authors:  Jill E Roughan; Kathryn M Reardon; Kristin E Cogburn; Heribert Quendler; Paul J Pockros; Mansun Law
Journal:  Clin Vaccine Immunol       Date:  2012-05-23

8.  Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.

Authors:  Gerson Dierley Keppeke; Minoru Satoh; Maria Lucia Gomes Ferraz; Edward K L Chan; Luís Eduardo C Andrade
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

9.  Is there an association between pemphigus and hepatitis viruses? A population-based large-scale study.

Authors:  Khalaf Kridin; Shira Zelber-Sagi; Doron Comaneshter; Arnon D Cohen
Journal:  Immunol Res       Date:  2017-10       Impact factor: 2.829

10.  Autoantibodies in hepatitis C: red flag or bystander effect?

Authors:  Michele M Tana; Theo Heller
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-03       Impact factor: 2.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.